HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Clinical trials for HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.

Never miss a new study

Get alerted when new HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear

Sign up with your email to follow new studies for HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Teens with inherited high cholesterol tracked for long-term drug safety

Disease control Ongoing

This study is checking the long-term safety of a cholesterol-lowering drug called inclisiran in teenagers with a genetic condition that causes very high cholesterol. It is an extension study for 131 teens who previously benefited from the drug in earlier trials. The main goal is …

Matched conditions: HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Get alerted when new HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear

Teens with inherited high cholesterol tracked for long-term drug safety